ABA Autism denied as duplicate or overlapping therapy by Humana?
If two medications appear duplicative on paper but serve different clinical purposes (e.g., short-acting vs long-acting), the appeal needs to spell out the clinical rationale for both.
US health-plan appeal rights
Cite: Most US health plans have appeal rights under either the ACA, ERISA, or Medicare/Medicaid rules
Most US health plans are required by federal law to give you both an internal appeal (where the insurer reconsiders) and an external review (where an independent reviewer decides). The exact timelines and processes depend on what kind of plan you have — marketplace / employer group, self-funded, Medicare Advantage, or Medicaid MCO — but in every case there's a window after the denial during which you have the right to fight it.
What Humana typically requires
Humana's specific coverage criteria for aba autism are defined in its own published medical/coverage policy and the FDA-approved prescribing label. A successful appeal documents that your medical records satisfy each criterion those sources list — confirmed diagnosis, any required prior treatments (with dates and outcomes), and clinical severity. If the exact criteria weren't included with your denial, request them in writing; your appeal then maps each requirement to the matching fact in your chart.
The Humana angle on ABA Autism
## Why Humana Denied ABA Therapy as "Duplicate Therapy" — and Why You Can Appeal
A duplicate-therapy denial means Humana has determined that another behavioral or developmental service already being received — such as speech therapy, occupational therapy, school-based services, or another behavioral program — overlaps sufficiently with ABA that covering both is not medically necessary. This rationale is legally and clinically weak when properly challenged. ABA, speech therapy, occupational therapy, and school-based IEP services are distinct in scope, methodology, and target skills. They frequently work in concert rather than substituting for one another. The treating team's clinical documentation should make these distinctions explicit.
Federal parity law (MHPAEA) also requires that any "duplicate therapy" standard applied to behavioral health services be no more restrictive than the standard applied to analogous medical services — for example, whether Humana would deny concurrent physical therapy and occupational therapy on duplication grounds.
## Federal Appeal Framework
- ACA §2719 / External Review: Approximately 180 days from denial to request independent external review. Expedited track available if standard timelines would jeopardize the child's health.
- ERISA §503: Written explanation of exactly which services Humana considers duplicative and the specific clinical rationale required under full-and-fair review.
- MHPAEA: Request Humana's comparative analysis of how duplication standards are applied to medical versus behavioral benefits under the same plan.
## Documentation to Gather
- Differentiation letter: A detailed letter from the ABA provider (and ideally each co-treating provider) explaining the distinct clinical purpose, methods, target behaviors, and goals of each service — and why they are complementary, not duplicative.
- Treatment plans for each service: Show that the skill domains, objectives, and methodologies of each service are non-overlapping.
- Coordination-of-care notes: Document how providers communicate and avoid redundancy.
- Diagnosis confirmation: Licensed clinician's written ASD diagnosis.
- Humana's policy: Obtain the coverage policy to identify the exact definition of "duplicate therapy" and map the evidence showing the services do not meet it.
## Criteria-Mapping Structure
For each element of Humana's duplicate-therapy definition, provide the specific chart and treatment-plan evidence showing the services are clinically distinct. Include a brief summary table: service name, primary methodology, target skill domain, treating provider, and how it differs from ABA.
Next steps
- Find the date on the denial letter — your appeal window starts there.
- Read your plan's Summary of Benefits and Coverage (SBC) for the specific deadlines.
- Request the insurer's claim file in writing — they must provide it.
- Submit your appeal in writing with new clinical evidence and a physician statement.
Get the letter drafted
DenialHelp drafts your appeal in 5 minutes — $40 list price, $30 for your first letter (use code SEO25). We cite the federal regs and the specific clinical evidence your plan responds to. Your physician signs and sends.
Start my appeal — $30 with code SEO25 →